On Aug. 9, the FDA expanded its list of valsartan products currently under recall to include other items that contain the active ingredient, which may be tainted with a carcinogenic impurity, manufactured by Hetero Labs Limited in India.

CMS proposed on Aug. 9 an overhaul to accountable care organizations (ACOs), which would require ACOs to more quickly assume financial risk. But critics predict the changes will cause a mass exodus from the Medicare Shared Savings Program.

DiA Imaging Analysis, a Be'er Sheva, Israel-based startup focused on artificial intelligence (AI) and medical imaging, announced this week that it has closed a $5 million round of funding.

Incidental pulmonary nodules detected on chest CT cost a downstream average of $393, researchers reported in a new Academic Radiology study. Collaboration may be the key to reducing that number.

The former business manager of a breast cancer center has been sentenced to 33 months in prison for wire fraud and tax fraud, according to an announcement by U.S. Attorney David C. Joseph.

Some scientists are showing concern after an experiment used a gene-editing tool to fix a potentially fatal heart condition in a human embryo, according to a report by The Wall Street Journal.

Strategic Radiology announced Thursday, Aug. 9, that Kansas City, Kansas-based United Imaging Consultants (UIC) has joined the company’s coalition of private practice radiologists.

The trade war between the U.S. and China continues to grow. The U.S. announced Tuesday, Aug. 7, that it will impose 25 percent tariffs on an additional $16 billion worth of goods imported from China.